Why the study?
The impact of ectonucleotidases such as CD73 on age-dependent atherosclerosis remains unclear.
Does genetic deletion of the ectonucleotidase CD73 alter the age-dependent accumulation of aortic atherosclerotic plaque in hyperlipidemic apoE-/- mice?
Does genetic deletion of the ectonucleotidase CD73 alter the age-dependent accumulation of aortic atherosclerotic plaque in hyperlipidemic apoE-/- mice?
This preclinical study demonstrates that while the ectonucleotidase CD73 exerts a mild protective effect against atherosclerosis in young mice, its effect reverses with aging to potently promote atherosclerotic plaque accumulation via adenosine-mediated suppression of lipolysis.
Answers are grounded in this paper and cite their sources.
Age-dependent CD73 effects on murine plaque warrant caution for human translation; extends knowledge of adenosine pathways in atherosclerosis.
Objective: CD73 is an ectonucleotidase which catalyzes the conversion of AMP (adenosine monophosphate) to adenosine. Adenosine has been shown to be anti-inflammatory and vasorelaxant. The impact of ectonucleotidases on age-dependent atherosclerosis remains unclear. Our aim was to investigate the role of CD73 in age-dependent accumulation of atherosclerosis. Approach and results: Mice doubly deficient in CD73 and ApoE (apolipoprotein E; ( cd73 − /− /apoE −/− ) were generated, and the extent of aortic atherosclerotic plaque was compared with apoE −/− controls at 12, 20, 32, and 52 weeks. By 12 weeks of age, cd73 −/− /apoE −/− mice exhibited a significant increase in plaque (1.4±0.5% of the total vessel surface versus 0.4±0.1% in apoE −/− controls, P <0.005). By 20 weeks of age, this difference disappeared (2.9±0.4% versus 3.3±0.7%). A significant reversal in phenotype emerged at 32 weeks (9.8±1.2% versus 18.3±1.4%; P <0.0001) and persisted at the 52 week timepoint (22.4±2.1% versus 37.0±2.1%; P <0.0001). The inflammatory response to aging was found to be comparable between cd73 −/− /apoE −/− mice and apoE −/− controls. A reduction in lipolysis in CD73 competent mice was observed, even with similar plasma lipid levels ( cd73 −/− /apoE −/− versus apoE −/− at 12 weeks [16.2±0.7 versus 9.5±1.4 nmol glycerol/well], 32 weeks [24.1±1.5 versus 7.4±0.4 nmol/well], and 52 weeks [13.8±0.62 versus 12.7±2.0 nmol/well], P <0.001). Conclusions: At early time points, CD73 exerts a subtle antiatherosclerotic influence, but with age, the pattern reverses, and the presence of CD73 promoted suppression of lipid catabolism.
No takes yet. Share an insight, caveat, or question.
Sutton et al. (2019) studied Age-dependent atherosclerosis (n=325). CD73 genetic deletion (cd73-/- / apoE-/- double knockout) vs. CD73-competent apolipoprotein E knockout (apoE-/-) control mice was evaluated on Percentage of total aortic vessel surface covered by atherosclerotic plaque at 52 weeks (p=<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: